Orchard Therapeutics plc Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Orchard Therapeutics plc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2023.
  • Orchard Therapeutics plc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2023 was $20M, a 13.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $20M -$3.13M -13.5% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $21M -$4.44M -17.4% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $21.9M -$5.46M -20% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $22.8M -$1.54M -6.34% Dec 31, 2022 10-Q 2023-11-13
Q3 2022 $23.1M -$3.13M -11.9% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $25.5M -$2.42M -8.68% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $27.4M -$1.33M -4.64% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $24.3M -$5.5M -18.4% Dec 31, 2021 10-K 2023-03-14
Q3 2021 $26.3M -$4.21M -13.8% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $27.9M +$9.23M +49.5% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $28.7M +$6.77M +30.9% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $29.8M +$10.4M +53.6% Dec 31, 2020 10-K 2022-03-30
Q3 2020 $30.5M Sep 30, 2020 10-Q 2020-11-03
Q2 2020 $18.6M Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $21.9M Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $19.4M Dec 31, 2019 10-K 2021-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.